Kratom, A Substance of Increasing Concern

November 28, 2018

Loading Events
  • This event has passed.
View Presentation Slides

Presenter(s): Thomas Penders, MD, Walter B Jones Ctr; East Carolina University; Cornel Stanciu, MD, MRO, Director of Addiction Services at New Hampshire Hospital and Assistant Professor of Psychiatry at Dartmouth’s Geisel School of Medicine

Recording link coming soon!

Target audience: Primary care and specialist physicians

Cost: No fee.

Webinar description: The leaves of Kratom, a small tree indigenous to Southeast Asia, have been used for centuries as a stimulant and medicinal. The active ingredients including the molecule Mitragynine, have some unique properties that have led to its use in many developed counties including the United States. Reports of several deaths have led the DEA to designate Kratom as a substance of concern. The pharmacological properties that make it unique include agonism at the opioid receptors providing incentive for individuals with opioid misuse to self-manage withdrawal symptoms when more powerful opioids are unavailable. This webinar will review the history, epidemiology, and pharmacology of Kratom. Guidelines for management of patients presenting with use of Kratom or withdrawal will be provided.

Educational objectives:

  • Recognize the salient aspects of Kratom’s background, psychoactive effects, and its pharmacological action
  • Review the state of knowledge about the impact of Kratom on mental health and its potentially dangerous adverse effects
  • Identify and manage Kratom withdrawal as well as provide maintenance treatment

Details

Date:
November 28
Time:
12:00 pm - 1:00 pm
Event Category:

Other

Presenter
Thomas Penders, MD, Walter B Jones Ctr; East Carolina University; Cornel Stanciu, MD, MRO, Director of Addiction Services at New Hampshire Hospital and Assistant Professor of Psychiatry at Dartmouth’s Geisel School of Medicine
Time Zone
ET